2017 American Transplant Congress
Neurogenic Orthostatic Hypotension: An Iatrogenic Complication of Successful Pancreas Transplantation?
1Houston Methodist Hospital, Houston, TX; 2Veloxis Pharmaceuticals, Cary, NC
Abrupt improvement in glycemic control is known to cause treatment-induced neuoropathies in poorly-controlled diabetes (DM).1 Similarly, neurogenic orthostatic hypotension (OH) is a well-known complication of…2017 American Transplant Congress
Apolipoprotein L1 & Chronic Kidney Disease Risk in Young Potential Living Kidney Donors.
Background: Living kidney donor selection practices have evolved from examining individual risk factors to a risk calculator incorporating multiple characteristics. Due to limited long-term data…2017 American Transplant Congress
Obesity Predicts New-Onset Diabetes After Live Kidney Donation.
End-stage renal disease is uncommon in living kidney donors (LKD), but recent data suggest that most kidney failure developing late after donation is due to…2017 American Transplant Congress
Lipid Abnormalities and Cardiovascular Events After Early Conversion to Everolimus in Kidney Transplant Recipients with Pretransplant Diabetes: 24-Month Analysis from Elevate Study.
1ELEVATE Study Group, Berlin, Germany; 2Novartis Pharma AG, Basel, Switzerland
PURPOSE: Pretransplant (preTx) diabetes is an independent risk factor for cardiovascular (CV) events, and posttransplant (post-Tx) hyperlipidemia further increases CV risk. To analyze the influence…2017 American Transplant Congress
Survival Outcomes from DCD Transplant Are Comparable to DBD Transplant from Kidneys Procured from Donors > 50 Years of Age. A UNOS/OPTN Propensity Score Matched Pair Analysis.
Multi-Organ Transplant Unit, London Health Sciences Centre, London, ON, Canada
Background:Caution is guarded in accepting offers from old donors due to risk of poor graft function. We aim to present the factors significantly determining the…2017 American Transplant Congress
Identifying Independent Risk Factors for Graft Loss After Primary Liver Transplantation: A Propensity Score Matched Analysis.
Core Facility Quality Management Transplantation, Hannover Medical School, Hannover, Germany
This study aims to identify independent risk factors for graft loss after primary liver transplantation beyond the occurrence of hepatic artery thrombosis. Graft loss was…2017 American Transplant Congress
Outcomes and Risk Factors for Graft Loss: Lessons Learned from More Than 1,056 Pediatric Kidney tx at a Single Center.
Aim:To study outcomes and risk factors for graft loss in > 1056 pediatric renal tx.Methods:We studied outcomes by immunosuppression era: I) 1963-83 (ALG, AZA and…2017 American Transplant Congress
Training for Transplant: Frailty Assessment and Optimization in Kidney Transplant Candidates.
Surgery, Scott & White Medical Center, Temple, TX
Purpose: To design and implement a frailty assessment and optimization program addressing potential modifiable risk factors that would ordinarily disqualify patients from kidney and/or pancreas…2017 American Transplant Congress
Risk Analysis of Patients with Proven Coronary Artery Disease Undergoing Liver Transplant.
Houston Methodist Hospital, Houston, TX
ObjectivesCoronary artery disease is increasing common in liver transplant (LT) candidates due to the aging population. We sought to longitudinally evaluate of outcomes of LT…2017 American Transplant Congress
Impact of Donor Genotype on Recipient Tacrolimus Pharmacokinetics: The Liver Matters.
1U of Cinicnnati, Cincinnati; 2Cincinnati Children's, Cincinnati; 3iC42 Clinical Research, Colorado
Tacrolimus (Tac) is a cornerstone immunosuppressant metabolized in the gut and liver, resulting in high intra/inter patient pharmacokinetic (PK) variability. Recipient genotype (RG) impacts tac…
- « Previous Page
- 1
- …
- 37
- 38
- 39
- 40
- 41
- …
- 55
- Next Page »